Central Research Division, Pfizer Inc., Groton, CT 06340, USA. john_a_lowe@groton.pfizer.com
Abstract:
The synthesis of NPTS, 6, a potent inhibitor of the type 1 glycine transporter (GlyT1) is described, as well as preparation of 6 in optically active and tritiated form for use as a radioligand for affinity displacement assay of GlyT1.